About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 3,051–3,060 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 3,023 |
Clinical Implant Dentistry and Related Research CLIN IMPLANT DENT R |
1523-0899 1708-8208 |
4.000 | 4.300 | Q1 | 14/162 | WILEY |
| 3,023 |
CLINICAL PHARMACOKINETICS CLIN PHARMACOKINET |
0312-5963 1179-1926 |
4.000 | 4.800 | Q1 | 82/352 | ADIS INT LTD |
| 3,023 |
CRISPR Journal CRISPR J |
2573-1599 2573-1602 |
4.000 | 3.800 | Q1 | 43/191 | MARY ANN LIEBERT, INC |
| 3,023 |
Current Opinion in HIV and AIDS CURR OPIN HIV AIDS |
1746-630X 1746-6318 |
4.000 | 3.500 | Q1 | 27/137 | LIPPINCOTT WILLIAMS & WILKINS |
| 3,023 |
CURRENT OPINION IN INFECTIOUS DISEASES CURR OPIN INFECT DIS |
0951-7375 1473-6527 |
4.000 | 3.900 | Q1 | 27/137 | LIPPINCOTT WILLIAMS & WILKINS |
| 3,023 |
Current Research in Biotechnology CURR RES BIOTECHNOL |
2590-2628 2590-2628 |
4.000 | 4.500 | Q2 | 50/177 | ELSEVIER |
| 3,023 |
DRUG METABOLISM AND DISPOSITION DRUG METAB DISPOS |
0090-9556 1521-009X |
4.000 | 3.600 | Q1 | 82/352 | ELSEVIER SCIENCE INC |
| 3,023 |
EFORT Open Reviews EFORT OPEN REV |
2396-7544 2058-5241 |
4.000 | 5.800 | Q1 | 15/139 | BIOSCIENTIFICA LTD |
| 3,023 |
Energy Efficiency ENERG EFFIC |
1570-646X 1570-6478 |
4.000 | 3.400 | Q2 | 56/191 | SPRINGER |
| 3,023 |
Energy Storage ENERGY STORAGE |
N/A 2578-4862 |
4.000 | 4.100 | Q3 | 99/182 | WILEY |